Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• CXC chemokine receptors (CXCRs) are increasingly studied in tumor biology.
• Prognostic significance of CXCR family members in acute myeloid leukemia (AML) remains underexplored.

Purpose of the Study:

• To analyze the relationship between CXCR family members and AML.
• To investigate the prognostic value of CXCR transcript expression in AML.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) database for sample analysis.
• Examined transcript expressions of CXCR family members in AML.
• Correlated CXCR expression with FAB classification, genotypes, and karyotypes.

Main Results:

• CXCR transcript expressions, excluding CXCR1, were significantly elevated in AML.
• Distinct expression patterns of CXCR members were observed across different AML subtypes.
• High CXCR2 expression correlated with significantly worse prognosis and identified it as an independent prognostic factor.

Conclusions:

• CXCR transcript expressions are crucial in AML pathogenesis and progression.
• A CXCR signature was developed, proving to be an independent prognostic factor for identifying high-risk AML subgroups.
• This CXCR signature offers a powerful tool for predicting patient survival rates in AML.